MX2017001900A - Composicion nasal con capacidades de formacion de pelicula. - Google Patents
Composicion nasal con capacidades de formacion de pelicula.Info
- Publication number
- MX2017001900A MX2017001900A MX2017001900A MX2017001900A MX2017001900A MX 2017001900 A MX2017001900 A MX 2017001900A MX 2017001900 A MX2017001900 A MX 2017001900A MX 2017001900 A MX2017001900 A MX 2017001900A MX 2017001900 A MX2017001900 A MX 2017001900A
- Authority
- MX
- Mexico
- Prior art keywords
- mixture
- nasal composition
- saline solution
- hyaluronic acids
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 229920002674 hyaluronan Polymers 0.000 title abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición nasal que comprende una base salina, un agente activo y una mezcla de un primer ácido hialurónico que tiene un peso molecular máximo de 105 daltons con un segundo ácido hialurónico que tiene un peso molecular de al menos 105 daltons. Dicha composición nasal está indicada para el tratamiento profiláctico o terapéutico de enfermedades de las vías respiratorias superiores, preferiblemente, mediante pulverización o formación de aerosol (spray) de dicha composición a un paciente que lo necesite.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14181205.7A EP2985027B1 (en) | 2014-08-16 | 2014-08-16 | Nasal composition comprising mixture of hyaluronic acids and saline solution |
| PCT/IB2015/001822 WO2016027160A2 (en) | 2014-08-16 | 2015-08-05 | Nasal composition with film-forming capacities |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017001900A true MX2017001900A (es) | 2017-04-27 |
| MX377823B MX377823B (es) | 2025-03-11 |
Family
ID=51383565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017001900A MX377823B (es) | 2014-08-16 | 2015-08-05 | Composición nasal con capacidades de formación de película. |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20170274006A1 (es) |
| EP (1) | EP2985027B1 (es) |
| MX (1) | MX377823B (es) |
| WO (1) | WO2016027160A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111265590B (zh) * | 2020-01-21 | 2022-03-01 | 华熙生物科技股份有限公司 | 一种用于鼻腔喷雾透明质酸冻干制剂及其制备方法和应用 |
| IT202000032243A1 (it) * | 2020-12-23 | 2022-06-23 | Fidia Farm Spa | Nuovi agenti antivirali |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166331A (en) | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| IE57931B1 (en) | 1983-10-11 | 1993-05-19 | Fidia Spa | Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same |
| US5079236A (en) | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
| JPH0232013A (ja) | 1988-07-20 | 1990-02-01 | Denki Kagaku Kogyo Kk | 点鼻剤 |
| WO1993015744A1 (en) | 1992-02-10 | 1993-08-19 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
| IT1271001B (it) | 1994-07-26 | 1997-05-26 | Poli Ind Chimica Spa | Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus |
| IT1287967B1 (it) | 1996-10-17 | 1998-09-10 | Fidia Spa In Amministrazione S | Preparazioni farmaceutiche per uso anestetico locale |
| FR2768630B1 (fr) | 1997-09-22 | 2000-08-04 | Ulice Sa | Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires |
| US20020086852A1 (en) | 1998-05-14 | 2002-07-04 | Cantor Jerome O. | Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| FR2780650B1 (fr) | 1998-07-03 | 2000-09-08 | Goemar Lab Sa | Solutions salines, leur procede de preparation et medicaments a base de ces solutions |
| US6004560A (en) | 1998-11-16 | 1999-12-21 | Hsu; Wu-Ching | Nasal spray (drop) for treating fever/cold, and its preparation |
| US20050232868A1 (en) | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| DE10161110A1 (de) | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US7060691B2 (en) | 2002-10-10 | 2006-06-13 | Giuseppe Petrigni | Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| FR2847818B1 (fr) | 2002-11-28 | 2008-04-04 | Agro Ind Rech S Et Dev Ard | Composition pharmaceutique a base d'acide hyaluronique |
| DE20318634U1 (de) | 2003-11-13 | 2004-02-26 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden |
| EP1718315A4 (en) | 2004-02-06 | 2008-08-13 | Univ Monash | HIGH DOSE USE OF SULFATED POLYSACCHARIDES IN SHORT INTERVALS FOR THE TREATMENT OF INFECTIONS |
| US20050224201A1 (en) | 2004-04-08 | 2005-10-13 | Kimberly-Clark Worldwide, Inc. | Treated crimped multi-ply product |
| US8642564B2 (en) | 2004-08-25 | 2014-02-04 | Aegis Therapeutics, Llc | Compositions for drug administration |
| GB0426068D0 (en) | 2004-11-29 | 2004-12-29 | Passion For Life Healthcare Lt | Composition with bacteria blocking action |
| US7524510B2 (en) | 2005-02-23 | 2009-04-28 | The Uab Research Foundation | Alkyl-glycoside enhanced vaccination |
| GB0602325D0 (en) | 2006-02-06 | 2006-03-15 | Remedy Res Ltd | Virucidal compositions and uses |
| ITMI20060742A1 (it) | 2006-04-13 | 2007-10-14 | Patrizia Pattini | Composizioni antibatteriche per il trattamento di infezioni delle alte e basse via aeree |
| US20090326193A1 (en) | 2006-06-23 | 2009-12-31 | Aegis Therapeutics Llc | Stabilizing alkylglycoside compositions and methods thereof |
| FR2915389B1 (fr) | 2007-04-26 | 2012-12-21 | De La Mer Laboratoire | Utilisation de solutions ioniques isoosmotiques a base d'eau de mer pour la fabrication de dispositifs medicaux pour la prevention des complications du rhume courant |
| CN101317847B (zh) | 2007-06-06 | 2010-10-13 | 深圳市瑞谷医药技术有限公司 | 一种眼用或耳鼻用药物组合物及其用途 |
| KR101449687B1 (ko) | 2008-03-13 | 2014-10-14 | 주식회사 바이오랜드 | 저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물 |
| DE102011010668A1 (de) | 2011-02-08 | 2012-08-09 | Ursapharm Arzneimittel Gmbh | Wässrige pharmazeutische Zusammensetzung zur Prävention und/oder Therapie allergisch gereizter Nasenschleimhaut und dessen Verwendung |
| PT2543357T (pt) | 2011-07-07 | 2018-04-30 | Holy Stone Healthcare Co Ltd | Resumo |
| FR2977494B1 (fr) | 2011-07-08 | 2013-08-16 | Ayawane | Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes |
| ES2665254T3 (es) | 2011-07-12 | 2018-04-25 | Holy Stone Healthcare Co., Ltd. | Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas |
| US20130039950A1 (en) | 2011-08-09 | 2013-02-14 | Church & Dwight Co., Inc. | Neti-pot packet mixture |
| CN105792835B (zh) | 2013-12-03 | 2022-03-25 | 格罗力马托斯国际有限公司 | 离子水性组合物 |
-
2014
- 2014-08-16 EP EP14181205.7A patent/EP2985027B1/en active Active
-
2015
- 2015-08-05 MX MX2017001900A patent/MX377823B/es unknown
- 2015-08-05 WO PCT/IB2015/001822 patent/WO2016027160A2/en not_active Ceased
- 2015-08-05 US US15/503,937 patent/US20170274006A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2985027A1 (en) | 2016-02-17 |
| WO2016027160A2 (en) | 2016-02-25 |
| EP2985027B1 (en) | 2021-03-31 |
| MX377823B (es) | 2025-03-11 |
| WO2016027160A3 (en) | 2016-04-14 |
| US20170274006A1 (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122189T1 (el) | Ιονικες υδατικες συνθεσεις | |
| MX392668B (es) | Composiciones nasales de cannabidiol | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| MX387277B (es) | Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada. | |
| EA201791916A1 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
| BR112012027055A8 (pt) | agente estabilizante para proteínas farmacêuticas. | |
| MX2016004316A (es) | Inhalador de polvo seco. | |
| BR112015011497A2 (pt) | composto, formulação farmacêutica, produto de combinação, e, método de tratamento de uma doença | |
| MX2018003569A (es) | Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos. | |
| BR112015017525A2 (pt) | peptídeo modificado, sal de um peptídeo modificado, medicamento, e, métodos para tratar ou aliviar uma doença cardiovascular e para produzir um peptídeo modificado | |
| MX377175B (es) | Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc). | |
| BR112015026053A2 (pt) | composição farmacêutica, recipiente vedado, inalador dosimetrado, e, métodos para tratamento de um paciente sofrendo ou susceptível a sofrer de um distúrbio respiratório e para fabricação de uma composição farmacêutica | |
| BRPI0915119B8 (pt) | uso de iota carragenano | |
| BR112015014174A2 (pt) | composição de vacina para indivíduos virgens | |
| FI3848028T3 (fi) | Okulaaristen sairauksien hoitomenetelmiä | |
| EA201692278A1 (ru) | Комбинации формотерола и будесонида для лечения хобл | |
| RU2017125688A (ru) | Антивирусная фармацевтическая композиция | |
| MX2017001900A (es) | Composicion nasal con capacidades de formacion de pelicula. | |
| BR112015022134A2 (pt) | composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção | |
| EA202090164A1 (ru) | Изотретиноиновые перорально-слизистые композиции и способы их применения | |
| MX2017001899A (es) | Composicion nasal que tiene propiedades antivirales. | |
| RU2018118986A (ru) | Фармацевтическая композиция для введения в слизистую носа | |
| BR112017022390A2 (pt) | composição farmacêutica | |
| BR112015028334A2 (pt) | agente e método para o tratamento de herpes | |
| MX383214B (es) | COMPOSICIONES Y MÉTODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA AUMENTAR LA RECUPERACIÓN DE TRAUMA DE TEJIDO BLANDO. |